Mostrando postagens com marcador Blood vessels. Mostrar todas as postagens
Mostrando postagens com marcador Blood vessels. Mostrar todas as postagens

terça-feira, 28 de abril de 2015

New material for creating artificial blood vessels

 

Tue, 04/28/2015 - 11:04am

Vienna Medical University

 

TU Wien and MedUni Vienna have developed artificial blood vessels, which are broken down by the body and replaced with its own tissue.

TU Wien and MedUni Vienna have developed artificial blood vessels, which are broken down by the body and replaced with its own tissue.VIENNA—Blocked blood vessels can quickly become dangerous. It is often necessary to replace a blood vessel—either by another vessel taken from the body or even by artificial vascular prostheses. Together, Vienna University of Technology and Vienna Medical University have developed artificial blood vessels made from a special elastomer material, which has excellent mechanical properties. Over time, these artificial blood vessels are replaced by endogenous material. At the end of this restorative process, a natural, fully functional vessel is once again in place. The method has already been used successfully in rats.

Arteriosclerotic vascular disorders are one of the most common causes of death in industrialized countries. In this situation a bypass operation is often the only solution. Normally, blood vessels are taken from another part of the patient's body and used to replace the damaged vessel. Thanks to a joint project undertaken by TU Wien and the Medical University of Vienna, artificially manufactured vessels should be used more frequently in future.

The most important thing is to find a suitable material. The artificial materials that have been used so far are not ideally compatible with body tissue. The blood vessel can easily become blocked, especially if it is only small in diameter.

TUW has therefore developed new polymers. "These are so-called thermoplastic polyurethanes," explains Robert Liska from the Institute of Applied Synthetic Chemistry of Vienna University of Technology. "By selecting very specific molecular building blocks we have succeeded in synthesizing a polymer with the desired properties."

A thin polymer thread spun into tubes

To produce the vascular prostheses, polymer solutions were spun in an electrical field to form very fine threads and wound onto a spool. "The wall of these artificial blood vessels is very similar to that of natural ones," says Heinz Schima of the Medical University of Vienna. The polymer fabric is slightly porous and so, initially, allows a small amount of blood to permeate through and this enriches the wall with growth factors. This encourages the migration of endogenous cells. The interaction between material and blood was studied by Martina Marchetti-Deschmann at TU Wien using spatially resolved mass spectrometry.

The new method has already proved very successful in experiments with rats. "The rats' blood vessels were examined six months after insertion of the vascular prostheses," says Helga Bergmeister of MedUni Vienna. “We did not find any aneurysms, thromboses or inflammation. Endogenous cells had colonized the vascular prostheses and turned the artificial constructs into natural body tissue." In fact, natural body tissue re-grew much faster than expected so that the degradation period of the plastic tubes can be even shorter. Further adaptations are currently being made to the material.

The project was recently awarded PRIZE prototype funding from Austria Wirtschaftsservice (AWS). A few more preclinical trials are necessary before the artificial blood vessels can be used in humans. However, based on the results so far, the research team is very confident that the new method will prove itself for use in humans in a few years’ time.

SOURCE: Vienna Medical University

sexta-feira, 23 de maio de 2014

Protective proteins reduce damage to blood vessels

 

May 21 / 2014

Biotechnology and Biological Sciences Research Council

Proteins found in our blood can reduce damage caused to blood vessels as we age, and in conditions such as atherosclerosis and arthritis, new research finds. Calcification is a major risk factor for heart attack and stroke. Blood vessels can harden as calcium phosphate (CaP) crystals, normally found in bones and teeth, build up in soft tissue as we age or as a result of illness. This can lead to complications in patients with atherosclerosis, a major cause of death whereby arteries thicken and are at risk of becoming blocked.


Calcium phosphate crystals (needle-shaped, indicated by arrows) being engulfed by a human vascular smooth muscle cell (SMC).

Researchers have uncovered how proteins found in our blood can reduce damage caused to blood vessels as we age, and in conditions such as atherosclerosis and arthritis.

Calcification is a major risk factor for heart attack and stroke. Blood vessels can harden as calcium phosphate (CaP) crystals, normally found in bones and teeth, build up in soft tissue as we age or as a result of illness. This can lead to complications in patients with atherosclerosis, a major cause of death in the UK whereby arteries thicken and are at risk of becoming blocked.

However a team of scientists at the BBSRC-funded Babraham Institute has discovered how CaP damages vessels, and how proteins normally found in our circulation can help prevent this process.

In the study funded by the British Heart Foundation, researchers found that small CaP crystals were being consumed by blood vessel cells, resulting in abnormally high levels of calcium ions, which can prove toxic.

They discovered that two proteins in the blood, fetuin-A and albumin, can slow down the uptake of CaP crystals by blood vessel cells, reducing the release of calcium ions and protecting against damage.

Dr Diane Proudfoot, who led the study, explained: "Small changes in calcium levels within a cell controls many aspects of normal cell function. However, when calcium levels become excessive, the cell can die. By delaying the uptake of these crystals and reducing the release of calcium ions, proteins fetuin-A and albumin can help to keep calcium ions at a safe level."

The research, published today in the journal PLOS ONE, offers potential to develop treatments to prevent and reduce the damaging effects of CaP crystals.

Dr Proudfoot added: "Interestingly, lower levels of these proteins have been observed in patients with chronic kidney disease who can suffer a higher level of mortality due to cardiovascular disease. In the future, there is potential to use fetuin-A that has been artificially created or extracted from blood as a treatment for patients with low levels of this protein."

Professor Melanie Welham, BBSRC Executive Director for Science, said: "BBSRC-funded science helps us to explore the biological processes that underpin our health. This research provides important insights into healthy aging and may lead to therapeutic strategies to prevent the problems associated with calcification in aging and several diseases."


Story Source:

The above story is based on materials provided by Biotechnology and Biological Sciences Research Council. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yana Dautova, Diana Kozlova, Jeremy N. Skepper, Matthias Epple, Martin D. Bootman, Diane Proudfoot. Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle Cells. PLoS ONE, 2014; 9 (5): e97565 DOI: 10.1371/journal.pone.0097565